Cargando…
Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic
The transcription factors Oct4, Sox2, Klf4, and c-Myc enable the reprogramming of somatic cells into induced pluripotent cells. Reprogramming generates newly differentiated cells for potential therapies in cancer, neurodegenerative diseases, and rejuvenation processes. In cancer therapies, these tra...
Autores principales: | Aguirre, Marisol, Escobar, Manuela, Forero Amézquita, Sebastián, Cubillos, David, Rincón, Camilo, Vanegas, Paula, Tarazona, María Paula, Atuesta Escobar, Sofía, Blanco, Juan Camilo, Celis, Luis Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531188/ https://www.ncbi.nlm.nih.gov/pubmed/37761837 http://dx.doi.org/10.3390/genes14091697 |
Ejemplares similares
-
Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs
por: Velychko, Sergiy, et al.
Publicado: (2019) -
Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer
por: Hong, Liwei, et al.
Publicado: (2023) -
Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms
por: Cai, Yanning, et al.
Publicado: (2015) -
Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4
por: Corbineau, Sébastien, et al.
Publicado: (2016) -
Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy
por: Nishiguchi, Masaki, et al.
Publicado: (2015)